Targeting SIRT1/AMPK/Nrf2/NF-кB by sitagliptin protects against oxidative stress-mediated ER stress and inflammation during ANIT-induced cholestatic liver injury
Rami Mosaoa, Mohammed W. Al-Rabia, Hani Z. Asfour, Nabil A. Alhakamy, Rasha A. Mansouri, Dina S. El‐Agamy, Wesam H. Abdulaal, Gamal A. Mohamed, Sabrin R. M. Ibrahim, Mahmoud Elshal
Topics & Concepts
Oxidative stressInflammationAMPKSitagliptinNF-κBChemistryLiver injuryPharmacologyMedicineInternal medicineMetforminEndocrinologyBiochemistryDiabetes mellitusEnzymeProtein kinase ALiver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and ProtectionPharmacological Effects of Natural Compounds